- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Supplemental insulin (insulin lispro)
Total 2804 results
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesChina
-
BiodelCompletedDiabetes MellitusUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesChina
-
Novo Nordisk A/SCompletedHealthy | DiabetesGermany
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesDenmark
-
Novo Nordisk A/SCompletedHealthy | DiabetesUnited States
-
GeropharmCompletedPharmacokinetics | BioequivalenceRussian Federation
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesJapan
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesJapan
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesMalaysia, Australia, Taiwan, Thailand, Hong Kong, Singapore, Philippines
-
Novo Nordisk A/SCompleted
-
Emory UniversityCompletedDiabetes Mellitus | Type 1 DiabetesUnited States
-
Novo Nordisk A/SCompletedHealthy | DiabetesGermany
-
Nanjing First Hospital, Nanjing Medical UniversityCompletedDiabetes Mellitus, Type 2China
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesMexico
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesNetherlands
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesJordan
-
SanofiCompleted
-
Rush University Medical CenterWithdrawn
-
Novo Nordisk A/SCompletedDiabetes | Type 2 Diabetes MellitusTaiwan, Turkey, India, Algeria, Hong Kong, China, Ukraine
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesSlovakia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesNorway, Sweden
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesTunisia
-
AdociaCompleted
-
Gan and Lee Pharmaceuticals, USACompletedDiabetes MellitusGermany
-
WockhardtWithdrawnBioequivalence in Healthy SubjectsUnited States
-
Novo Nordisk A/SCompletedHealthy | DiabetesSouth Africa
-
Novo Nordisk A/SCompletedHealthy | DiabetesJapan
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesSouth Africa
-
SanofiCompletedDiabetes MellitusUnited States
-
Novo Nordisk A/SCompletedHealthy | DiabetesSouth Africa
-
University of AarhusCompletedHypoglycemia | Diabetes Mellitus Type IDenmark
-
Riverside University Health System Medical CenterTerminated
-
SanofiCompleted
-
Diasome Pharmaceuticlas, Inc.RecruitingDiabetes Mellitus, Type 1United States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesCanada
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Delivery SystemsIndonesia
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1South Africa
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1Romania
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesPoland, Spain, Sweden, Malaysia, France, Netherlands, India, Argentina, South Africa, Romania, Former Serbia and Montenegro, Austria, Czech Republic, Philippines, Mexico
-
WockhardtWithdrawnBioequivalence in Healthy SubjectsUnited States
-
Eli Lilly and CompanyCompleted
-
Halozyme TherapeuticsCompletedDiabetes Mellitus, Type 1United States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States
-
Novo Nordisk A/SCompletedObservational Study to Evaluate the Safety and Efficacy of NovoMix® 70 in Type 2 Diabetes (INTENSIV)Diabetes Mellitus, Type 2 | DiabetesAustria
-
Joslin Diabetes CenterBoston Children's HospitalCompletedType 1 Diabetes
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesPoland, United Kingdom, Spain, Denmark, France, Netherlands, Austria, Hungary, Russian Federation, Germany, Turkey, Italy, Bulgaria, Romania, Belgium, Switzerland, Slovenia, Czech Republic
-
Halozyme TherapeuticsCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesHungary
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesIndia